RxDoctor Payments DataLook up a doctor →

Suhel Ahmed, MD

Internal Medicine · Hackensack, NJNPI 1801042072

Payments from drug & device makers

$82,386in general payments, 2019–2025

Across 607 payments — averaging $135.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$63K
  • Intra-sana Laboratories$11K
  • Pfizer$745
  • Boston Scientific$698
  • AbbVie$601
  • Exact Sciences$385
  • plus $6K from 54 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Novo Nordisk218$62,762
Intra-sana Laboratories26$11,431
Pfizer49$745
Boston Scientific7$698
AbbVie(2 entities)53$601
Exact Sciences12$385
AstraZeneca(2 entities)17$366
GSK24$358
Boehringer Ingelheim7$311
Bayer10$293
Daiichi Sankyo Inc.15$247
Medtronic(2 entities)3$228
Biosense Webster, Inc.3$226
Abbott8$217
Lilly USA, LLC13$217
Johnson & Johnson13$199
Gilead14$190
Axsome Therapeutics, Inc.5$171
Asensus Surgical, Inc.3$166
Dexcom, Inc.3$166
Corcept Therapeutics3$161
Biotronik NRO, Inc.3$151
Amgen(2 entities)11$149
Abiomed1$148
Qapel Medical Inc1$147
Novartis2$141
Lexicon Pharmaceuticals, Inc.1$125
Currax Pharmaceuticals LLC7$111
Astellas Pharma US Inc5$104
Amneal Pharmaceuticals LLC1$100
Amarin Pharma, Inc.7$92
Vivus LLC6$89
Endo Pharmaceuticals Inc.5$72
Philips North America LLC3$62
Merck4$60
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC4$59
Biohaven Pharmaceuticals, Inc.4$58
Arbor Pharmaceuticals, Inc.4$54
Otsuka America Pharmaceutical, Inc.4$53
Phadia US Inc.3$48
Biohaven Pharmaceutical Holding Company Ltd.3$44
Viiv Healthcare Company2$37
Kerecis Limited1$36
Intuity Medical Inc2$36
Insightec,inc1$28
Nalpropion Pharmaceuticals LLC2$25
Inspire Medical Systems, Inc.1$21
Phathom Pharmaceuticals, Inc.1$19
Bausch Health US, LLC1$18
Invivyd Inc1$18
3b Medical, Inc.1$18
Mannkind Corporation1$16
Rhythm Pharmaceuticals, Inc.1$16
Azurity Pharmaceuticals, Inc.1$15
Takeda Pharmaceuticals U.S.A., Inc.1$14
Xeris Pharmaceuticals, Inc.1$14
CSL Behring1$13
Sanofi-aventis U.S. LLC1$13
Kowa Pharmaceuticals America, Inc.1$13
Echosens North America, Inc.1$11

How this compares

$82,386 in reported general payments places this provider in the 95th percentile of 4,032 internal medicine providers in New Jersey.

See all internal medicine providers in New Jersey →

Medicare billing

Part B allowed, 2024
$272,269
Medicare patients
436
Services billed
3,425

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other internal medicine in Hackensack

See the full list for New Jersey →

Where these figures come from

Is this you, or does something look wrong? →